<Disease><Name>NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY (NLSDM)</Name><Synonym>NEUTRAL LIPID STORAGE DISEASE WITHOUT ICHTHYOSIS</Synonym><OMIM><Number>610717</Number><URL>http://omim.org/entry/610717</URL></OMIM><Orphanet><Number>98908</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=98908</URL></Orphanet><Protein><Number>Patatin-like phospholipase domain-containing protein 2</Number><URL>https://www.uniprot.org/uniprot/Q96AD5</URL></Protein><ExPASy><Number /><URL /></ExPASy><Gene>11p15.5</Gene><ICD>E75.5</ICD><Summary>rare;autosomal recessive;mutation in the PNPLA2 gene</Summary><Symptoms><symtomp><id>2470</id><symptom>areflexia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2459</id><symptom>cardiac arrhythmia, dysrhythmia</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>2104</id><symptom>cardiomyopathy</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1948</id><symptom>defect of walking, running, rising or climbing</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3062</id><symptom>diabetes mellitus</symptom><category>GASTROINTESTINAL SYSTEM | LABORATORY FINDINGS</category></symtomp><symtomp><id>1837</id><symptom>exercise intolerance</symptom><category>MUSCLES</category></symtomp><symtomp><id>1901</id><symptom>fasciculations</symptom><category>MUSCLES</category></symtomp><symtomp><id>2433</id><symptom>hearing defect, deafness</symptom><category>EARS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2147</id><symptom>muscle cramps</symptom><category>MUSCLES</category></symtomp><symtomp><id>1787</id><symptom>muscle weakness</symptom><category>MUSCLES</category></symtomp><symtomp><id>1786</id><symptom>myopathy</symptom><category>MUSCLES</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2029</id><symptom>pain, muscle / myalgia, pain muscle</symptom><category>GENERAL TOPICS | MUSCLES</category></symtomp><symtomp><id>3202</id><symptom>rhabdomyolysis</symptom><category>MUSCLES</category></symtomp><symtomp><id>2109</id><symptom>short stature</symptom><category>GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>694</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>40.00</min><max>400.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>309</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>40.00</min><max>150.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>308</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>60.00</min><max>400.00</max><unit>U/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>947</id><name>Creatine kinase</name><specimen>serum</specimen><value>increased</value><min>25.00</min><max>90.00</max><unit>U/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>294</id><name>Triglycerides</name><specimen>serum</specimen><value>normal/inc</value><min>40.00</min><max>128.00</max><unit>mg/dl</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>491</id><name>Triglycerides</name><specimen>serum</specimen><value>normal/inc</value><min>30.00</min><max>99.00</max><unit>mg/dl</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1008</id><name>Triglycerides</name><specimen>various tissues</specimen><value>normal/inc</value><min>    </min><max>    </max><unit>no data</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>6219</id><title>Neutral lipid storage disease with myopathy: Further phenotypic characterization of a rare PNPLA2 variant</title><author>Latimer CS,</author><journal>Neuromuscul Disord</journal><year>2018</year><book /><volume>28</volume><number>7</number><pages>606-660</pages><co_aut>et al.</co_aut></literature><literature><id>6220</id><title>Patients with neutral lipid storage disease with myopathy (NLSDM) in Southwestern China</title><author>Tan J,</author><journal>Clin Neurol Neurosurg</journal><year>2018</year><book /><volume>168</volume><number>0</number><pages>102-107</pages><co_aut>et al.</co_aut></literature><literature><id>6221</id><title>Muscle MRI in neutral lipid storage disease (NLSD)</title><author>Garibaldi M,</author><journal>J Neurol</journal><year>2017</year><book /><volume>264</volume><number>7</number><pages>1334-1342</pages><co_aut>et al.</co_aut></literature><literature><id>6222</id><title>Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients</title><author>Pennisi EM,</author><journal>Orphanet J Rare Dis</journal><year>2017</year><book /><volume>12</volume><number>1</number><pages>90</pages><co_aut>et al.</co_aut></literature><literature><id>6223</id><title>Neutral lipid-storage disease with myopathy and extended phenotype with novel PNPLA2 mutation</title><author>Massa R,</author><journal>Muscle Nerve</journal><year>2016</year><book /><volume>53</volume><number>4</number><pages>644-648</pages><co_aut>et al.</co_aut></literature><literature><id>6224</id><title>Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy</title><author>Missaglia S,</author><journal>Mol Genet Metab</journal><year>2015</year><book /><volume>115</volume><number>2</number><pages>110-117</pages><co_aut>et al.</co_aut></literature><literature><id>6228</id><title>Novel PNPLA2 gene mutations in Chinese Han patients causing neutral lipid storage disease with myopathy</title><author>Lin P,</author><journal>J Hum Genet</journal><year>2012</year><book /><volume>57</volume><number>10</number><pages>679-681</pages><co_aut>et al.</co_aut></literature><literature><id>6227</id><title>The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene</title><author>Reilich P,</author><journal>J Neurol</journal><year>2011</year><book /><volume>258</volume><number>11</number><pages>1987-1997</pages><co_aut>et al.</co_aut></literature><literature><id>6225</id><title>The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy</title><author>Fischer J,</author><journal>Nat Genet</journal><year>2007</year><book /><volume>39</volume><number>1</number><pages>28-30</pages><co_aut>et al.</co_aut></literature><literature><id>6226</id><title>Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with </title><author>Akiyama M,</author><journal>Muscle Nerve</journal><year>2007</year><book /><volume>36</volume><number>6</number><pages>856-859</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>